Preemptive Rituximab for Epstein-Barr Virus Reactivation after Hematopoietic Cell Transplantation: Necessary for All? [0.03%]
造血干细胞移植后预防性使用利妥昔单抗治疗Epstein-Barr病毒再活化：所有人都需要吗？
Anna Beatriz Coelho de Souza,Anderson João Simione,Ana Cláudia Ferrari Dos Santos et al.
Anna Beatriz Coelho de Souza et al.
Introduction: In allogeneic HCT recipients, risk factors for PTLD and EBV end-organ diseases are well established. Therefore, weekly monitoring of EBV reactivation with quantitative PCR is indicated for patients at risk. ...
Siti Mardhiah Muhamad Fauzi,Cybele Lara Abad,Jacques Simkins et al.
Siti Mardhiah Muhamad Fauzi et al.
This case describes a 62-year-old male who underwent kidney transplantation and was admitted 8 weeks post-operatively for evaluation and management of abdominal pain, nausea, and diarrhea. An extensive workup was performed, ultimately leadi...
Scalp-Sparing Facial Demodicosis Mimicking Acute Cutaneous GVHD after Allogeneic HSCT: A Clinicopathologic Confirmation and Rapid Therapeutic Response [0.03%]
allo-HSCT后头皮完整型面部毛囊蠕形螨病误诊为急性皮肤GVHD 1例及临床病理对照和快速治疗反应
Samet Öner,Ceylan Avcı,Erdoğan Anık
Samet Öner
What Would You Choose? Oral CMV Prophylaxis in Maintenance Hemodialysis Patients After Solid Organ Transplantation [0.03%]
你会如何选择？固器官移植后维持血透患者的巨细胞病毒口服预防治疗
Hidemasa Akazawa,Shinnosuke Fukushima,Hideharu Hagiya
Hidemasa Akazawa
Implementation of a Protocol With a Shortened Vancomycin Prophylaxis Duration is Associated With Reduced Acute Kidney Injury in Lung Transplant Recipients: A Quasi-Experimental Study [0.03%]
缩短万古霉素预防性用药时间的实施与降低肺移植受者的急性肾损伤有关：准实验研究
Paige T Stratton,Mary Grace Fitzmaurice,Rachel M Kenney et al.
Paige T Stratton et al.
Background: Vancomycin plus an antipseudomonal β-lactam are common antibiotics used for lung transplant surgical prophylaxis, but the optimal post-operative duration is unknown. The study objective was to assess the impa...
Hospital Acquired Infections Among Solid Organ Transplant Recipients Hospitalized in Intensive Care Unit (2018-2024): A Study of the GiViTI Group [0.03%]
GiViTI组2018-2024年重症监护病房住院实体器官移植受者医院感染研究
Camilla Genovese,Martina Offer,Marta Colaneri et al.
Camilla Genovese et al.
Introduction: Limited data exist regarding the burden of intensive care unit (ICU)-acquired infections in the early post-solid organ transplant (SOT) period, particularly in multidrug resistant organisms-endemic settings....
Disseminated Varicella-Zoster Virus Infection in Organ Transplant Recipients: A 10-year Retrospective Study [0.03%]
器官移植受者带状疱疹病毒散在感染的回顾性研究
Ryosuke Yamamuro,Alba Romero,Ahsha Khandelwal-Young et al.
Ryosuke Yamamuro et al.
Background: Data on disseminated herpes zoster (HZ) infections in solid organ transplant (SOT) recipients are limited. We aimed to investigate the clinical characteristics and outcomes of HZ infection in SOT patients pres...
Unmasking Parvovirus B19 Infection After Allogeneic HSCT: Early Recognition and Effective Management [0.03%]
同种异体造血干细胞移植后未被识别的B19感染：早期诊断和有效治疗
Nicole Hess,Kyle Hansotia,Gabriela Sanchez-Petitto
Nicole Hess
The Relevance of Perioperative Respiratory Viral Infection Detection in Lung Transplant Recipients: Should We Reconsider Our Practices? [0.03%]
肺移植受者围手术期呼吸道病毒感染检测的相关性：我们应该重新考虑我们的实践吗？
Andrea Lombardi,Giulia Renisi
Andrea Lombardi
Twice Weekly Sulfamethoxazole/Trimethoprim for Pneumocystis jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients [0.03%]
肺移植受者预防卡氏肺孢子虫肺炎的复方新诺明隔日给药方案
Chloe Munroe,Alissa Chan,Morgan Eiting et al.
Chloe Munroe et al.
Background: Pneumocystis jiroveci pneumonia (PJP) prophylaxis is recommended indefinitely for lung transplant recipients (LTR). To mitigate the side effects of oral sulfamethoxazole-trimethoprim (SMX/TMP) in LTR, our cent...